Keros Therapeutics (KROS) Other Working Capital Changes: 2019-2025
Historic Other Working Capital Changes for Keros Therapeutics (KROS) over the last 7 years, with Sep 2025 value amounting to -$1.8 million.
- Keros Therapeutics' Other Working Capital Changes rose 68.99% to -$1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 69.11%. This contributed to the annual value of $10.2 million for FY2024, which is 10.05% up from last year.
- As of Q3 2025, Keros Therapeutics' Other Working Capital Changes stood at -$1.8 million, which was down 173.22% from $2.5 million recorded in Q2 2025.
- In the past 5 years, Keros Therapeutics' Other Working Capital Changes registered a high of $6.4 million during Q2 2024, and its lowest value of -$5.9 million during Q3 2024.
- Its 3-year average for Other Working Capital Changes is $1.4 million, with a median of $2.5 million in 2025.
- Examining YoY changes over the last 5 years, Keros Therapeutics' Other Working Capital Changes showed a top increase of 1,584.32% in 2023 and a maximum decrease of 299.63% in 2023.
- Keros Therapeutics' Other Working Capital Changes (Quarterly) stood at -$1.3 million in 2021, then soared by 120.35% to $270,000 in 2022, then slumped by 299.63% to -$539,000 in 2023, then spiked by 1,073.28% to $5.2 million in 2024, then spiked by 68.99% to -$1.8 million in 2025.
- Its Other Working Capital Changes stands at -$1.8 million for Q3 2025, versus $2.5 million for Q2 2025 and -$4.5 million for Q1 2025.